Clinical Trial Update: Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO [Phase 2]

View source ↗

Summary

This Phase 2 open-label study assessing AKB-9778 for macular edema due to retinal vein occlusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• AKB-9778

Snippet

Sponsor: Aerpio Therapeutics | Conditions: Retinal Vein Occlusion | Phase 2 | Status: COMPLETED